Boulet Jacinthe, Cunningham Jonathan W, Mehra Mandeep R
Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts, USA.
JACC Basic Transl Sci. 2022 Jun 15;7(7):716-729. doi: 10.1016/j.jacbts.2022.05.003. eCollection 2022 Jul.
The increased need for heart transplantation in patients with advanced heart failure has introduced demand for a greater supply of donor hearts. Progress in cross-species experimental models has led to promise for ushering in the clinical use of xenotransplantation (XTx) as a potential solution to the organ shortage worldwide. In this review, the authors first highlight the historical advances that led to the first pig-to-human heart transplantation, a landmark moment in the field of advanced heart failure. The authors discuss immunologic, infectious, and physiological challenges for implementation of XTx, as well as innovations in the science of genetic manipulation that allowed clinical translation of this therapy. The authors consider ongoing barriers that affect ongoing translation of this technology into clinical care in the current era. Finally, the authors propose a framework for advancing clinical application of XTx.
晚期心力衰竭患者对心脏移植的需求增加,这使得对供体心脏的供应量有了更大的需求。跨物种实验模型的进展为将异种移植(XTx)引入临床应用带来了希望,这是解决全球器官短缺问题的潜在解决方案。在这篇综述中,作者首先强调了促成首例猪到人的心脏移植的历史进展,这是晚期心力衰竭领域的一个里程碑时刻。作者讨论了实施XTx所面临的免疫、感染和生理挑战,以及基因操作科学方面的创新,这些创新使该疗法得以临床转化。作者考虑了在当前时代影响该技术持续转化为临床护理的持续障碍。最后,作者提出了一个推进XTx临床应用的框架。